secwatch.observer — SEC 8-K summary
======================================

Issuer:     Personalis, Inc. (PSNL)
CIK:        0001527753
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060202
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Personalis Q3 revenue up 23% to $18.2M; raises FY2023 guidance
--------------------------------------------------------------

- Revenue $18.2M (+23% YoY); net loss $29.1M, EPS -$0.60 including $5.6M impairment.
- Full-year 2023 revenue guidance raised to $73-74M (prior $70-72M); Q4 guided $19-20M.
- Pharma/enterprise revenue $15.8M (+7% YoY); Natera contributed $7.9M.
- TRACERx data: NeXT Personal up to 4x sensitivity vs other liquid biopsies; detects lung cancer 6-11 months before imaging.
- Cash $120.7M; FY2023 cash usage <$70M vs $119M in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527753/000095017023060202/0000950170-23-060202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527753/000095017023060202/psnl-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer